AstraZeneca PLC

Stocks

AZN

GB0009895292

Market Closed - London S.E. 01:35:08 19/08/26 am AEST			5-day change	1st Jan Change
11,806.00 ^GBX	+2.13%		-0.32%	-14.39%

02:02am	FTSE 100 holds modest gains as Brent tops USD90	AN
01:40am	Stockholm stocks fell again on Tuesday, the OMXS30 index slipped 0.7 percent	FW

Transcript : AstraZeneca PLC - Special Call

Published on 07/07/2026 at 03:05 am AEST

S&P Capital IQ

Presenter Speech
Philip Sparks (Executives)

Welcome, everyone, to AstraZeneca's 2026 Sustainability Update for Investors and Analysts. I'm Philip Sparks, Director of Investor Relations. And before we

This article is reserved for our subscribers.

To unlock the article,
subscribe!

Full unlimited browsing across the entire site

Access to all the news and all the data

Access to US, EUROPE AND ASIA Portfolios

Zero Ads for a completely uninterrupted reading experience

Pro Tools: Expert insights, Expert Screeners, historical financial data and reports, thematic lists, transcripts...

Latest news about AstraZeneca PLC

02:02am	FTSE 100 holds modest gains as Brent tops USD90	AN
01:40am	Stockholm stocks fell again on Tuesday, the OMXS30 index slipped 0.7 percent	FW
01:14am	European Equities Traded in the US as American Depositary Receipts Head Lower in Tuesday Trading	MT
05:49pm	Oil surge, pound slip aids FTSE 100 but peers fall	AN
18/08	Health Care Down on Growth Doubts - Health Care Roundup	DJ
18/08	FTSE 100 falls for sixth day in a row as consumer stocks weigh	RE
18/08	UK Shares Start Week Downbeat; AstraZeneca Shares Data from Lung Cancer Trials	MT
18/08	European Stocks Close Lower in Monday Trading Despite Tech, Mining Stocks Rally	MT
17/08	BofA Notes AstraZeneca's Volrustomig Late-stage Study Fail; Buy Maintained	MT
17/08	AstraZeneca Demonstrates Statistically Significant and Clinically Meaningful Improvements with TAGRISSO Plus Savolitinib in Saffron Phase III Trial	CI
17/08	FTSE 100 set to snap six-day losing streak as miners gain	RE
17/08	AstraZeneca Discontinues EVOLVE-Lung02 Phase III Trial Of Volrustomig Plus Chemotherapy In Metastatic Non-Small Cell Lung Cancer	CI
17/08	AstraZeneca PLC : JP Morgan remains its Buy rating	ZD
17/08	AstraZeneca Ends Phase Three Lung Cancer Drug Trial After Review -- Update	DJ
17/08	European Midday Briefing : Shares Mixed as Iran Ceasefire Set to Expire	DJ